Wednesday, September 23, 2026

USD/EUR Bearish Momentum: 0.87% Down In The Last 5 Sessions

USD/EUR Bearish Momentum: 0.87% Down In The Last 5 Sessions

(VIANEWS) - USD/EUR (USDEUR) has been up by 0.87% for the last 5 sessions. At 13:06 EST on Thursday, 25 April, USD/EUR (USDEUR) is $0.93.

USD/EUR's yearly highs and lows, it's 5.006% up from its 52-week low and 2.685% down from its 52-week high.

Volatility

USD/EUR's last week, last month's, and last quarter's current intraday variation average was a negative 0.07%, a positive 0.04%, and a positive 0.25%, respectively.

USD/EUR's highest amplitude of average volatility was 0.19% (last week), 0.25% (last month), and 0.25% (last quarter), respectively.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, USD/EUR's Forex is considered to be overbought (>=80).

News about

  • Eur/usd stays firm, shy of 1.0700 amid strong US dollar and elevated US yields. According to FXStreet on Wednesday, 24 April, "Besides that, EUR/USD traders would be eyeing the release of the Core Personal Consumption Expenditures (PCE) Price Index, the Federal Reserve's preferred inflation gauge, which is estimated to remain steady at 0.3%. ", "Even though the EUR/USD seems to have bottomed at around 1.0600, buyers' failure to achieve a daily close above 1.0700 could pave the way for a re-test of the year-to-date (YTD) low at 1.0601. "
  • Eur/usd recovers after US economic myth dented. According to FXStreet on Wednesday, 24 April, "It is now less certain EUR/USD is forming a Bear Flag price pattern as had previously been assumed. "
  • Eur/usd extends holding pattern ahead of pmis. According to FXStreet on Tuesday, 23 April, "S&P Global PMIs for America will be releasedduring the US session and are likely to further impact the EUR/USD pair."
  • Eur/usd price analysis: tests the major level of 1.0650; followed by the nine-day EMA. According to FXStreet on Tuesday, 23 April, "Moreover, the lagging indicator, Moving Average Convergence Divergence (MACD), indicates weakness for the EUR/USD pair as it resides below the centerline and the signal line. ", "On the upside, the immediate barrier for the EUR/USD pair could be the nine-day Exponential Moving Average (EMA) at 1.0675. "
  • Eur/usd price analysis: moves above 1.0700, next barrier at 21-day EMA. According to FXStreet on Thursday, 25 April, "Additionally, the lagging indicator Moving Average Convergence Divergence (MACD) indicates a shift in momentum for the EUR/USD pair, as it is positioned below the centerline but above the signal line. ", "Key support for the EUR/USD pair is likely to be found around the psychological level of 1.0700. "

More news about USD/EUR (USDEUR).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Frontier AI Slowdown Call Splits Industry, Rattles Capex-Sensitive Markets
Anthropic's Dario Amodei publicly called for a coordinated global slowdown in frontier AI development, a stance Microsoft echoed with a 'humanist' AI code of conduct, but Nvidia and Meta's CEOs rejected any coordinated pause days later, exposing a widening rift between safety-focused and growth-focused AI leaders. The dispute landed amid growing financial scrutiny of AI infrastructure spending — a hyperscaler capex analysis, FTC warnings against antitrust waivers for AI firms, and an 8.6% single-day stock drop in GE Vernova tied directly to the slowdown remarks — signaling investors are newly nervous about whether the AI capex boom (including Alphabet's projected $701B revenue narrative) can be justified if the pace of development itself becomes contested.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,983
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,983 facts checked against source5,304 source documents archived
Query this data → isubstrate.com